Apollo Endosurgery Inc EBITDA margin
Qual é o EBITDA margin de Apollo Endosurgery Inc?
O EBITDA margin de Apollo Endosurgery Inc é -60.86%
Qual é a definição de EBITDA margin?
EBITDA margin is a profitability ratio that measures how much EBITDA the company generates as a percentage of revenue.
ttm (trailing twelve months)
EBITDA margin measures how much of EBITDA is generated as a percentage of sales. It measures the company’s operating profit as a percentage of its revenue and is calculated as EBITDA (earnings before interest, taxes, depreciation, and amortization) divided by total revenue.
EBITDA margin also helps with judging the effectiveness of cost-cutting processes at the company. The higher the company’s EBITDA margin, the lower operating expenses are in respect to revenue. As a result, a higher EBITDA margin is considered more favorable. Smaller companies can have higher EBITDA margins since they are able to operate more efficiently and maximize their profitability.
EBITDA excludes interest on debt, taxes, and capital expenditures, the margin does not provide a perfectly clear estimate of the business’s cash flow generation. Furthermore, EBITDA margin is not recognized as a GAAP (generally accepted accounting principles) metric.
EBITDA margin de empresas na Setor Health Care em NASDAQ em comparação com Apollo Endosurgery Inc
O que Apollo Endosurgery Inc faz?
Apollo Endosurgery, Inc. is a medical technology company focused on less invasive therapies to treat various gastrointestinal conditions, ranging from gastrointestinal defect repairs to the interventional treatment of obesity. Apollo's device-based therapies are an alternative to invasive surgical procedures, thus lowering complication rates and reducing total healthcare costs. Apollo's products are offered in over 75 countries today and include the X-Tack™ Endoscopic HeliX Tacking System, the OverStitch™ Endoscopic Suturing System, the OverStitch Sx™ Endoscopic Suturing System, and the ORBERA® Intragastric Balloon.
Empresas com ebitda margin semelhantes a Apollo Endosurgery Inc
- Megalith tem EBITDA margin de -61.33%
- Sailfish Royalty tem EBITDA margin de -61.30%
- Echo Plc tem EBITDA margin de -61.25%
- Avita Medical tem EBITDA margin de -61.20%
- Hutchison China MediTech tem EBITDA margin de -61.12%
- Tu Yi tem EBITDA margin de -60.99%
- Apollo Endosurgery Inc tem EBITDA margin de -60.86%
- Aurinia Pharmaceuticals tem EBITDA margin de -60.84%
- Hostelworld plc tem EBITDA margin de -60.83%
- Taal Distributed Information Technologies tem EBITDA margin de -60.81%
- Weimob tem EBITDA margin de -60.69%
- Cluey Ltd tem EBITDA margin de -60.68%
- Waterdrop tem EBITDA margin de -60.59%